LRI Investments’s Passage Bio PASG Stock Holding History

LRI Investments’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59	Hold	12	–	–	﹤0.01%	1894
2026 Q1	$94	Hold	12	–	–	﹤0.01%	1405
2025 Q4	$142	Hold	12	–	–	﹤0.01%	1340
2025 Q3	$96	Buy	12 +1	+9%	+$7	﹤0.01%	1296
2025 Q2	$90	Hold	11	–	–	﹤0.01%	1253
2025 Q1	$79	Hold	11	–	–	﹤0.01%	1201
2024 Q4	$128	Hold	11	–	–	﹤0.01%	1146
2024 Q3	$133	Hold	11	–	–	﹤0.01%	1138
2024 Q2	$179	Hold	11	–	–	﹤0.01%	1128
2024 Q1	$304	Buy	+11	New	+$265	﹤0.01%	828

LRI Investments's PASG Position: Q2 2026 in Review

LRI Investments held its Passage Bio (PASG) position steady in Q2 2026 at 12 shares worth $59. The position accounts for ﹤0.01% of the portfolio, ranked #1894.

LRI Investments first reported a position in PASG in Q1 2024 and has held it in 10 quarters since. The position peaked at $304 in Q1 2024. 1 fund tracked by Wall St. Rank holds PASG as of Q2 2026.

LRI Investments held 12 shares of Passage Bio worth $59 as of Q2 2026.
LRI Investments left its Passage Bio share count unchanged in Q2 2026.
Passage Bio made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1894 holding.
LRI Investments first reported a position in Passage Bio in Q1 2024 and has held it in 10 quarters since.
LRI Investments's Passage Bio position peaked at $304 in Q1 2024.
1 fund tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.